Loading…
Transileocolic Portal Vein Embolization Increases Remnant Liver Volume After Major Hepatectomy
Transileocolic portal vein embolization (TIPE) may reduce the risk of liver failure after massive hepatectomy. However, convincing evidence of its usefulness in this regard is yet to be reported. Therefore, this study aimed to investigate the use of TIPE after massive hepatectomy. Twelve patients wh...
Saved in:
Published in: | In vivo (Athens) 2024-11, Vol.38 (6), p.2761-2766 |
---|---|
Main Authors: | , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 2766 |
container_issue | 6 |
container_start_page | 2761 |
container_title | In vivo (Athens) |
container_volume | 38 |
creator | Kimura, Koichi Minagawa, Ryosuke Yamaoka, Terutoshi Izumi, Takuma Takahashi, Y U Nakanishi, Mitsuru Tokunaga, Takayuki Matsuda, Daisuke Nobuto, Yoshinari Yano, Hiroko Kajiwara, Yuichiro Honma, Kenichi Nagata, Shigeyuki Minami, Kazuhito Nishizaki, Takashi |
description | Transileocolic portal vein embolization (TIPE) may reduce the risk of liver failure after massive hepatectomy. However, convincing evidence of its usefulness in this regard is yet to be reported. Therefore, this study aimed to investigate the use of TIPE after massive hepatectomy.
Twelve patients who underwent TIPE were included. Pre- and postoperative liver volumetry was determined using a 3D simulator with computed tomography.
After TIPE, the percent change in total liver volume was 104.0%±13.1% (p=0.08). Conversely, the percent increase in remnant liver volume (ml)/total liver volume (ml) and remnant liver volume (ml)/standard liver volume (ml) was 122.9%±18.6% (p |
doi_str_mv | 10.21873/invivo.13755 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11535930</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3122638498</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1895-145661e7264f55585ed4ec529eb3bf502e2ca25c81631c6ea9c1e413d94ed0b83</originalsourceid><addsrcrecordid>eNpVkc1PGzEQxS3UioS0R67IRy4bPP7YXZ8QimhBCqKqKOqplteZpUa7drA3keCvJ5A0oqfRzDy996QfIcfAphzqSpz5sPbrOAVRKXVAxlBpKCol9ScyZlzVRa3g94gc5fzIWFkxxg_JSGhZVZLLMflzl2zIvsPoYucd_RHTYDt6jz7Qy77Z3F7s4GOg18EltBkz_Yl9sGGgc7_GRO9jt-qRXrTDZrmxjzHRK1zaAd0Q--cv5HNru4xfd3NCfn27vJtdFfPb79ezi3nhoNaqAKnKErDipWyVUrXChUSnuMZGNK1iHLmzXLkaSgGuRKsdoASx0BIXrKnFhJxvfZerpseFwzAk25ll8r1NzyZab_7_BP_XPMS1AVBCacE2Dqc7hxSfVpgH0_vssOtswLjKRgDnpailfgsrtlKXYs4J230OMPMOxWyhmHcoG_3Jx3J79T8K4hXmCYtZ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3122638498</pqid></control><display><type>article</type><title>Transileocolic Portal Vein Embolization Increases Remnant Liver Volume After Major Hepatectomy</title><source>PubMed Central</source><creator>Kimura, Koichi ; Minagawa, Ryosuke ; Yamaoka, Terutoshi ; Izumi, Takuma ; Takahashi, Y U ; Nakanishi, Mitsuru ; Tokunaga, Takayuki ; Matsuda, Daisuke ; Nobuto, Yoshinari ; Yano, Hiroko ; Kajiwara, Yuichiro ; Honma, Kenichi ; Nagata, Shigeyuki ; Minami, Kazuhito ; Nishizaki, Takashi</creator><creatorcontrib>Kimura, Koichi ; Minagawa, Ryosuke ; Yamaoka, Terutoshi ; Izumi, Takuma ; Takahashi, Y U ; Nakanishi, Mitsuru ; Tokunaga, Takayuki ; Matsuda, Daisuke ; Nobuto, Yoshinari ; Yano, Hiroko ; Kajiwara, Yuichiro ; Honma, Kenichi ; Nagata, Shigeyuki ; Minami, Kazuhito ; Nishizaki, Takashi</creatorcontrib><description>Transileocolic portal vein embolization (TIPE) may reduce the risk of liver failure after massive hepatectomy. However, convincing evidence of its usefulness in this regard is yet to be reported. Therefore, this study aimed to investigate the use of TIPE after massive hepatectomy.
Twelve patients who underwent TIPE were included. Pre- and postoperative liver volumetry was determined using a 3D simulator with computed tomography.
After TIPE, the percent change in total liver volume was 104.0%±13.1% (p=0.08). Conversely, the percent increase in remnant liver volume (ml)/total liver volume (ml) and remnant liver volume (ml)/standard liver volume (ml) was 122.9%±18.6% (p<0.001) and 132.2%±19.6% (p<0.001), respectively. TIPE operation time was 125±84.6 min, with minimal blood loss in all cases. Postoperative hospitalization duration during TIPE was 4.5±2.6 days. No TIPE-related complications occurred in any patient.
TIPE is beneficial and safe when preoperative volumetry indicates that the remaining liver volume is inadequate and inoperable.</description><identifier>ISSN: 0258-851X</identifier><identifier>ISSN: 1791-7549</identifier><identifier>EISSN: 1791-7549</identifier><identifier>DOI: 10.21873/invivo.13755</identifier><identifier>PMID: 39477424</identifier><language>eng</language><publisher>Greece: International Institute of Anticancer Research</publisher><subject>Adult ; Aged ; Embolization, Therapeutic - methods ; Female ; Hepatectomy - methods ; Humans ; Liver - diagnostic imaging ; Liver - pathology ; Liver - surgery ; Liver Neoplasms - surgery ; Liver Neoplasms - therapy ; Male ; Middle Aged ; Organ Size ; Portal Vein ; Tomography, X-Ray Computed ; Treatment Outcome</subject><ispartof>In vivo (Athens), 2024-11, Vol.38 (6), p.2761-2766</ispartof><rights>Copyright © 2024, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.</rights><rights>2024 The Author(s). Published by the International Institute of Anticancer Research. 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11535930/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11535930/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39477424$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kimura, Koichi</creatorcontrib><creatorcontrib>Minagawa, Ryosuke</creatorcontrib><creatorcontrib>Yamaoka, Terutoshi</creatorcontrib><creatorcontrib>Izumi, Takuma</creatorcontrib><creatorcontrib>Takahashi, Y U</creatorcontrib><creatorcontrib>Nakanishi, Mitsuru</creatorcontrib><creatorcontrib>Tokunaga, Takayuki</creatorcontrib><creatorcontrib>Matsuda, Daisuke</creatorcontrib><creatorcontrib>Nobuto, Yoshinari</creatorcontrib><creatorcontrib>Yano, Hiroko</creatorcontrib><creatorcontrib>Kajiwara, Yuichiro</creatorcontrib><creatorcontrib>Honma, Kenichi</creatorcontrib><creatorcontrib>Nagata, Shigeyuki</creatorcontrib><creatorcontrib>Minami, Kazuhito</creatorcontrib><creatorcontrib>Nishizaki, Takashi</creatorcontrib><title>Transileocolic Portal Vein Embolization Increases Remnant Liver Volume After Major Hepatectomy</title><title>In vivo (Athens)</title><addtitle>In Vivo</addtitle><description>Transileocolic portal vein embolization (TIPE) may reduce the risk of liver failure after massive hepatectomy. However, convincing evidence of its usefulness in this regard is yet to be reported. Therefore, this study aimed to investigate the use of TIPE after massive hepatectomy.
Twelve patients who underwent TIPE were included. Pre- and postoperative liver volumetry was determined using a 3D simulator with computed tomography.
After TIPE, the percent change in total liver volume was 104.0%±13.1% (p=0.08). Conversely, the percent increase in remnant liver volume (ml)/total liver volume (ml) and remnant liver volume (ml)/standard liver volume (ml) was 122.9%±18.6% (p<0.001) and 132.2%±19.6% (p<0.001), respectively. TIPE operation time was 125±84.6 min, with minimal blood loss in all cases. Postoperative hospitalization duration during TIPE was 4.5±2.6 days. No TIPE-related complications occurred in any patient.
TIPE is beneficial and safe when preoperative volumetry indicates that the remaining liver volume is inadequate and inoperable.</description><subject>Adult</subject><subject>Aged</subject><subject>Embolization, Therapeutic - methods</subject><subject>Female</subject><subject>Hepatectomy - methods</subject><subject>Humans</subject><subject>Liver - diagnostic imaging</subject><subject>Liver - pathology</subject><subject>Liver - surgery</subject><subject>Liver Neoplasms - surgery</subject><subject>Liver Neoplasms - therapy</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Organ Size</subject><subject>Portal Vein</subject><subject>Tomography, X-Ray Computed</subject><subject>Treatment Outcome</subject><issn>0258-851X</issn><issn>1791-7549</issn><issn>1791-7549</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNpVkc1PGzEQxS3UioS0R67IRy4bPP7YXZ8QimhBCqKqKOqplteZpUa7drA3keCvJ5A0oqfRzDy996QfIcfAphzqSpz5sPbrOAVRKXVAxlBpKCol9ScyZlzVRa3g94gc5fzIWFkxxg_JSGhZVZLLMflzl2zIvsPoYucd_RHTYDt6jz7Qy77Z3F7s4GOg18EltBkz_Yl9sGGgc7_GRO9jt-qRXrTDZrmxjzHRK1zaAd0Q--cv5HNru4xfd3NCfn27vJtdFfPb79ezi3nhoNaqAKnKErDipWyVUrXChUSnuMZGNK1iHLmzXLkaSgGuRKsdoASx0BIXrKnFhJxvfZerpseFwzAk25ll8r1NzyZab_7_BP_XPMS1AVBCacE2Dqc7hxSfVpgH0_vssOtswLjKRgDnpailfgsrtlKXYs4J230OMPMOxWyhmHcoG_3Jx3J79T8K4hXmCYtZ</recordid><startdate>202411</startdate><enddate>202411</enddate><creator>Kimura, Koichi</creator><creator>Minagawa, Ryosuke</creator><creator>Yamaoka, Terutoshi</creator><creator>Izumi, Takuma</creator><creator>Takahashi, Y U</creator><creator>Nakanishi, Mitsuru</creator><creator>Tokunaga, Takayuki</creator><creator>Matsuda, Daisuke</creator><creator>Nobuto, Yoshinari</creator><creator>Yano, Hiroko</creator><creator>Kajiwara, Yuichiro</creator><creator>Honma, Kenichi</creator><creator>Nagata, Shigeyuki</creator><creator>Minami, Kazuhito</creator><creator>Nishizaki, Takashi</creator><general>International Institute of Anticancer Research</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>202411</creationdate><title>Transileocolic Portal Vein Embolization Increases Remnant Liver Volume After Major Hepatectomy</title><author>Kimura, Koichi ; Minagawa, Ryosuke ; Yamaoka, Terutoshi ; Izumi, Takuma ; Takahashi, Y U ; Nakanishi, Mitsuru ; Tokunaga, Takayuki ; Matsuda, Daisuke ; Nobuto, Yoshinari ; Yano, Hiroko ; Kajiwara, Yuichiro ; Honma, Kenichi ; Nagata, Shigeyuki ; Minami, Kazuhito ; Nishizaki, Takashi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1895-145661e7264f55585ed4ec529eb3bf502e2ca25c81631c6ea9c1e413d94ed0b83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Embolization, Therapeutic - methods</topic><topic>Female</topic><topic>Hepatectomy - methods</topic><topic>Humans</topic><topic>Liver - diagnostic imaging</topic><topic>Liver - pathology</topic><topic>Liver - surgery</topic><topic>Liver Neoplasms - surgery</topic><topic>Liver Neoplasms - therapy</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Organ Size</topic><topic>Portal Vein</topic><topic>Tomography, X-Ray Computed</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kimura, Koichi</creatorcontrib><creatorcontrib>Minagawa, Ryosuke</creatorcontrib><creatorcontrib>Yamaoka, Terutoshi</creatorcontrib><creatorcontrib>Izumi, Takuma</creatorcontrib><creatorcontrib>Takahashi, Y U</creatorcontrib><creatorcontrib>Nakanishi, Mitsuru</creatorcontrib><creatorcontrib>Tokunaga, Takayuki</creatorcontrib><creatorcontrib>Matsuda, Daisuke</creatorcontrib><creatorcontrib>Nobuto, Yoshinari</creatorcontrib><creatorcontrib>Yano, Hiroko</creatorcontrib><creatorcontrib>Kajiwara, Yuichiro</creatorcontrib><creatorcontrib>Honma, Kenichi</creatorcontrib><creatorcontrib>Nagata, Shigeyuki</creatorcontrib><creatorcontrib>Minami, Kazuhito</creatorcontrib><creatorcontrib>Nishizaki, Takashi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>In vivo (Athens)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kimura, Koichi</au><au>Minagawa, Ryosuke</au><au>Yamaoka, Terutoshi</au><au>Izumi, Takuma</au><au>Takahashi, Y U</au><au>Nakanishi, Mitsuru</au><au>Tokunaga, Takayuki</au><au>Matsuda, Daisuke</au><au>Nobuto, Yoshinari</au><au>Yano, Hiroko</au><au>Kajiwara, Yuichiro</au><au>Honma, Kenichi</au><au>Nagata, Shigeyuki</au><au>Minami, Kazuhito</au><au>Nishizaki, Takashi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Transileocolic Portal Vein Embolization Increases Remnant Liver Volume After Major Hepatectomy</atitle><jtitle>In vivo (Athens)</jtitle><addtitle>In Vivo</addtitle><date>2024-11</date><risdate>2024</risdate><volume>38</volume><issue>6</issue><spage>2761</spage><epage>2766</epage><pages>2761-2766</pages><issn>0258-851X</issn><issn>1791-7549</issn><eissn>1791-7549</eissn><abstract>Transileocolic portal vein embolization (TIPE) may reduce the risk of liver failure after massive hepatectomy. However, convincing evidence of its usefulness in this regard is yet to be reported. Therefore, this study aimed to investigate the use of TIPE after massive hepatectomy.
Twelve patients who underwent TIPE were included. Pre- and postoperative liver volumetry was determined using a 3D simulator with computed tomography.
After TIPE, the percent change in total liver volume was 104.0%±13.1% (p=0.08). Conversely, the percent increase in remnant liver volume (ml)/total liver volume (ml) and remnant liver volume (ml)/standard liver volume (ml) was 122.9%±18.6% (p<0.001) and 132.2%±19.6% (p<0.001), respectively. TIPE operation time was 125±84.6 min, with minimal blood loss in all cases. Postoperative hospitalization duration during TIPE was 4.5±2.6 days. No TIPE-related complications occurred in any patient.
TIPE is beneficial and safe when preoperative volumetry indicates that the remaining liver volume is inadequate and inoperable.</abstract><cop>Greece</cop><pub>International Institute of Anticancer Research</pub><pmid>39477424</pmid><doi>10.21873/invivo.13755</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0258-851X |
ispartof | In vivo (Athens), 2024-11, Vol.38 (6), p.2761-2766 |
issn | 0258-851X 1791-7549 1791-7549 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11535930 |
source | PubMed Central |
subjects | Adult Aged Embolization, Therapeutic - methods Female Hepatectomy - methods Humans Liver - diagnostic imaging Liver - pathology Liver - surgery Liver Neoplasms - surgery Liver Neoplasms - therapy Male Middle Aged Organ Size Portal Vein Tomography, X-Ray Computed Treatment Outcome |
title | Transileocolic Portal Vein Embolization Increases Remnant Liver Volume After Major Hepatectomy |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T06%3A20%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Transileocolic%20Portal%20Vein%20Embolization%20Increases%20Remnant%20Liver%20Volume%20After%20Major%20Hepatectomy&rft.jtitle=In%20vivo%20(Athens)&rft.au=Kimura,%20Koichi&rft.date=2024-11&rft.volume=38&rft.issue=6&rft.spage=2761&rft.epage=2766&rft.pages=2761-2766&rft.issn=0258-851X&rft.eissn=1791-7549&rft_id=info:doi/10.21873/invivo.13755&rft_dat=%3Cproquest_pubme%3E3122638498%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1895-145661e7264f55585ed4ec529eb3bf502e2ca25c81631c6ea9c1e413d94ed0b83%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3122638498&rft_id=info:pmid/39477424&rfr_iscdi=true |